Search research articles
Contact Us
Filters
Showing results (1-10 of 47) with videos related to
Page
of 5
Sort By:
The Journal of Community and Supportive Oncology
|
June 28, 2014
Afatinib approval for NSCLC brings EGFR TKI story full circle
James P Stevenson
The Oncologist
|
July 26, 2014
Current issues in malignant pleural mesothelioma evaluation and management
Jing Ai, James P Stevenson
Oncotargets and Therapy
|
December 10, 2016
The evolution of the diminishing role of extrapleural pneumonectomy in the surgical management of malignant pleural mesothelioma
Abdel-Ghani Azzouqa, James P Stevenson
Cancer Chemotherapy and Biological Response Modifiers
|
April 22, 2003
Cancers of the large bowel and hepatobiliary tract
Tracy S d'Entremont, James P Stevenson
JAMA Oncology
|
March 12, 2016
Perspectives in Oncology Drug Pricing
James P Stevenson, Matt Kalaycio, Brian Bolwell
Journal of Pain and Symptom Management
|
June 5, 2007
Frameworks for prescribing in comorbid illness
James P Stevenson, David C Currow, Amy P Abernethy
Journal of Palliative Care
|
December 12, 2007
The broader implications of managing statins at the end of life
James P Stevenson, David C Currow, Amy P Abernethy
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 18, 2011
New strategies in non-small cell lung cancer: improving outcomes in chemoradiotherapy for locally advanced disease
Ramesh Rengan, Amit M Maity, James P Stevenson, et al.
JTO Clinical and Research Reports
|
July 11, 2022
Impact of Socioeconomic Factors on Overall Survival in SCLC
Logan Roof, Wei Wei, Katherine Tullio, et al.
Cancer Chemotherapy and Pharmacology
|
June 18, 2003
Phase I combination trial of gemcitabine, paclitaxel, and carboplatin in patients with advanced malignancy
Keith T Flaherty, James P Stevenson, Stephen M Hahn, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 47) with videos related to
Sort By:
Page
of 5
The Journal of Community and Supportive Oncology
|
June 28, 2014
Afatinib approval for NSCLC brings EGFR TKI story full circle
James P Stevenson
The Oncologist
|
July 26, 2014
Current issues in malignant pleural mesothelioma evaluation and management
Jing Ai, James P Stevenson
Oncotargets and Therapy
|
December 10, 2016
The evolution of the diminishing role of extrapleural pneumonectomy in the surgical management of malignant pleural mesothelioma
Abdel-Ghani Azzouqa, James P Stevenson
Cancer Chemotherapy and Biological Response Modifiers
|
April 22, 2003
Cancers of the large bowel and hepatobiliary tract
Tracy S d'Entremont, James P Stevenson
JAMA Oncology
|
March 12, 2016
Perspectives in Oncology Drug Pricing
James P Stevenson, Matt Kalaycio, Brian Bolwell
Journal of Pain and Symptom Management
|
June 5, 2007
Frameworks for prescribing in comorbid illness
James P Stevenson, David C Currow, Amy P Abernethy
Journal of Palliative Care
|
December 12, 2007
The broader implications of managing statins at the end of life
James P Stevenson, David C Currow, Amy P Abernethy
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 18, 2011
New strategies in non-small cell lung cancer: improving outcomes in chemoradiotherapy for locally advanced disease
Ramesh Rengan, Amit M Maity, James P Stevenson, et al.
JTO Clinical and Research Reports
|
July 11, 2022
Impact of Socioeconomic Factors on Overall Survival in SCLC
Logan Roof, Wei Wei, Katherine Tullio, et al.
Cancer Chemotherapy and Pharmacology
|
June 18, 2003
Phase I combination trial of gemcitabine, paclitaxel, and carboplatin in patients with advanced malignancy
Keith T Flaherty, James P Stevenson, Stephen M Hahn, et al.
Page
of 5